sotalol   Click here for help

GtoPdb Ligand ID: 7297

Synonyms: Betapace® | MJ-1999
Approved drug
sotalol is an approved drug (FDA (1992))
Compound class: Synthetic organic
Comment: Sotalol is a β-blocker & potassium channel blocker.
Marketed formulations may contain sotalol hydrochloride (PubChem CID 66245).
Click here for help
IUPHAR Pharmacology Education Project (PEP) logo

View more information in the IUPHAR Pharmacology Education Project: sotalol

2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 5
Hydrogen bond donors 3
Rotatable bonds 6
Topological polar surface area 86.81
Molecular weight 272.12
XLogP 1.05
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CC(NCC(c1ccc(cc1)NS(=O)(=O)C)O)C
Isomeric SMILES CC(NCC(c1ccc(cc1)NS(=O)(=O)C)O)C
InChI InChI=1S/C12H20N2O3S/c1-9(2)13-8-12(15)10-4-6-11(7-5-10)14-18(3,16)17/h4-7,9,12-15H,8H2,1-3H3
InChI Key ZBMZVLHSJCTVON-UHFFFAOYSA-N
No information available.
Summary of Clinical Use Click here for help
Used to treat cardiac arrythymias.
In October 2014, Solytize® became the first oral preparation containing sotalol hydrochloride to gain approval for the treatment of life-threatening ventricular arrhythmias (US FDA approval).
Mechanism Of Action and Pharmacodynamic Effects Click here for help
This drug antagonises cardiac β-adrenoceptors. It also blocks inward potassium channel currents, prolonging repolarisation and slowing conduction at the atrioventricular (AV) node. See the DrugBank link for further details.
External links Click here for help